Smith and Land demonstrated in colon cancer cells that ABCA1 had an anticancer activity in which deficiency allowed for increased mitochondrial cholesterol, inhibited release of mitochondrial cell death-promoting molecules, and facilitated cancer cell survival [32]. Here, ABCA1 is linked to malignant colon neoplasm.